Form 4: Elanco Director Receives Equity Award

Deborah Turner Kochevar, a Director at Elanco Animal Health Inc., was granted deferred stock units as part of an annual equity award.

Summary

• Deborah Turner Kochevar, a Director at Elanco Animal Health Inc. (ELAN), received a grant of 4,678 deferred stock units on May 21, 2026.
• This award is described as a pro-rated annual equity award for non-employee members of the Issuer's Board of Directors.
• Following this transaction, Kochevar beneficially owns 94,392 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity award to a director and does not contain new financial performance data or strategic shifts.

Positives

• Director Kochevar received an equity award, aligning her interests with shareholders.
• The award is part of a standard annual equity program for non-employee directors.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's equity award.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the animal health industry to incentivize long-term performance and align executive and director interests with those of shareholders.

Stakeholder Impact

• Shareholders: The equity award aligns director interests with those of shareholders, potentially encouraging decisions that benefit long-term stock value.
• Employees: This filing does not directly impact employees, but it is part of the overall compensation structure for the company's leadership.

Key Dates

Keywords

Elanco Animal Health, ELAN, Form 4, Insider Trading, Equity Award, Deferred Stock Units, Director Compensation, Beneficial Ownership